Epidemiology, pathogenicity and emerging resistances in Staphylococcus pasteuri: from mammals and lampreys, to man. Recent patents on anti-infective drug discovery [Recent Pat Antiinfect Drug Discov] Journal article | | Title | Epidemiology, pathogenicity and emerging resistances in Staphylococcus pasteuri: from mammals and lampreys, to man. | | Author(s) | Savini V, Catavitello C, Bianco A, Balbinot A, D'Antonio D | | Institution | Department of Transfusion Medicine, 'Spirito Santo' Hospital, Pescara, Italy. vincsavi@yahoo.it | | Source | Recent Pat Antiinfect Drug Discov 2009 Jun; 4(2):123-9. | | Abstract | Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19519547 |
|
|
| |
Advertise on this site.
| | |
|
